Rory Riggs has been actively involved in the biotechnology industry for over 25 years as a leading entrepreneur, executive, and venture capitalist. He has been the co-founder and chairman/director of many leading companies in healthcare and biotech including: Royalty Pharma, Fibrogen, Sugen, GeneNews and Cibus. He also served as the president and director of Biomatrix Corporation (NYSE: BXM) where he launched Synvisc, an important product in the treatment of osteoarthritis. Rory is currently CEO (Founder) of Locus/Syntax where he is applying attribute-based data analytic technology from healthcare to finance and economics. He was a co-founder and managing member of Scientia Venture’s predecessor: New Venture Funds.

Rory received a BA from Middlebury College and an MBA from Columbia University.

‍